Asher Mullard Vague experimental protocols was one barrier to replication that researchers encountered. Credit: Patrick Hertzog/AFP/Getty A US$2-million, 8-year attempt to replicate influential preclinical cancer research papers has released its final — and disquieting — results. Fewer than half of the experiments assessed stood up to scrutiny, reports the Reproducibility Project: Cancer Biology (RPCB) team...
